Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease

作者：Feyza Bayram Catak, Mehmet Cihangir Çatak, Royala Babayeva, John Toubia, Nicholas I. Warnock, Fatih Çelmeli, Demet Hafizoglu, Nalan Yakıcı, Başak Kayaoğlu, Naz Sürücü, Ezgi Yalcin Gungoren, Salim Can, Melek Yorgun Altunbaş, İbrahim Serhat Karakuş, Ayça Aslan Kıykım, Fazıl Orhan, Sevgi Bilgiç Eltan, Elif Karakoç-Aydıner, Ahmet Oguzhan Ozen, Baran Erman, Mayda Gürsel, Chung Hoow Kok, Gökhan Cildir, Safa Barış · 发表于：Journal of Allergy and Clinical Immunology · 年份：2024 · DOI：10.1016/j.jaci.2024.11.032 · 被引用次数：8 · 研究领域：Immunodeficiency and Autoimmune Disorders、Cytokine Signaling Pathways and Interactions、Chronic Lymphocytic Leukemia Research